Live Breaking News & Updates on Genomic surveillance unit

Molecular tumor profiling in pediatric cancer patients significantly impacts clinical care

Results of a study of molecular tumor profiling in young patients revealed a high rate of genetic alterations with potential for impacting clinical care, including clarifying diagnoses and treatment with matched, precision cancer drugs.

United-states , Boston , Massachusetts , Dana-farber-cancer-institute , Katherinea-janeway , Emily-henderson , Blood-disorders-center , Harvard-medical-school , Alannaj-church , Nature-medicine , Boston-children , Senior-physician

Genomic Vision Obtains the Renewal of the ISO 13485: 2016 Certification

Regulatory News: GENOMIC VISION (FR0011799907 GV) (Paris:GV)Within the compliance cycle of Standard NF EN ISO 13485 by the subsidiary GMED (LNE Group), an independent notified body empowered by

United-states , Paris , France-general- , France , Bagneux , French , America , Dominique-remy-renou , Mohamed-salah-garouachi , Health-products-safety , Strategic-communications , Quality-regulatory-affairs

Genomic Vision granted a new patent for its Physical Characterization of Telomeres technique based on molecular combing

Regulatory News: Genomic Vision(the "Company" FR0011799907 GV) (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome

Paris , France-general- , France , Bagneux , Dominique-remy-renou , Trademark-office , Strategic-communications , Euronext , Genomic-vision-the-company , World-intellectual-property-organization , Regulatory-news , Genomic-vision

Genomic analysis of the 2022 monkeypox outbreak

In a recent study posted to the bioRxiv pre-print server, researchers analyzed two genomic sequences of the Monkeypox virus from Belgium and Portugal termed ITM001 and PT0001, respectively, to show that the May 2022 Monkeypox outbreak most likely originated from the West African clade of the virus.

Germany , Australia , United-states , Netherlands , United-kingdom , Belgium , Italy , Central-african-republic , Sweden , Portugal , Canada , France

Genomic Testing Cooperative, LCA: Genomic Testing Cooperative Hematology Profile Plus, Solid Tumor Profile Plus, and Liquid Biopsy Profiles Receive CE-IVD Mark

Genomic Testing Cooperative (GTC) today announced it received CE-IVD marks for its Hematology Profile Plus, Solid Tumor Plus as well as its liquid biopsy profiles for both solid tumors and hematology

Germany , Kostenloser-wertpapierhandel , Therapyselect-heidelberg , Maher-albitar , Jennifer-varca , Frank-kischkel , Genomic-testing-cooperative , Genomic-testing , Hematology-profile-plus , Solid-tumor-plus , Solid-tumor-profile-plus , Hematology-liquid-biopsy-profile

Genomic Vision Announces the Approval by Its Shareholders' Meeting of All the Resolutions Supported by the Executive Board

Regulatory News: Genomic Vision(FR0011799907 GV the "Company"), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, informs its

Paris , France-general- , France , Bagneux , Dominique-remy-renou , Strategic-communications , Euronext , Regulatory-news , Extraordinary-shareholder-meeting , Des-meuniers , Investors-general , Genomic-vision

Genomic Vision Announces the Signing of an Addendum to the Contract Signed with Winance on April 11, 2022 for the Purpose of Implementing a New Financing Line, Subject to the Prior Approval of the Company's Shareholders

This addendum alters the formula for calculating the number of shares liable to result from the exercise of the equity warrants (BSA) that will be attached to the convertible notes that will be issued

United-states , Paris , France-general- , France , Bagneux , French , Dominique-remy-renou , Investor-relations-strategic-communications , Bloomberg , Company-universal-registration-document , Nanterre-commercial-court , Euronext

New method improves polygenic prediction of disease risk across diverse populations

Polygenic risk scores (PRS) are promising tools for predicting disease risk, but current versions have built-in bias that can affect their accuracy in some populations and result in health disparities.

China , Shanghai , Sying-he , Guizhou , Massachusetts , United-states , Yunfeng-ruan , Hailiang-huang , Emily-henderson , Broad-institute , Ying-he-foundation , National-institute-of-diabetes

Genomic Vision: Financial Information for the First Quarter of 2022

Revenue from sales up 72% Revenue from activity up 78% Cash position of €1.3 million at end-March 2022 Regulatory News: Genomic Vision(FR0011799907 GV the "Company") (Paris:GV)

Paris , France-general- , France , Bagneux , Bracknor-negma , Dominique-remy-renou , Strategic-communications , Company-paris , Research-tax-credit , Euronext , Genomic-vision , Extraordinary-general-meeting

Genomic Vision: 2021 Annual Results

Revenue from activity up 9% in 2021, to €1.4 million Good control over current operating expenses (-5.5%) Financial resources offering visibility through to end-May 2022 Implementation

Paris , France-general- , France , Bagneux , Bracknor-negma , Dominique-remy-renou , Strategic-communications , Company-paris , Research-tax-credit , Research-development , Euronext , Sales-marketing